10
Participants
Start Date
October 2, 2023
Primary Completion Date
October 26, 2023
Study Completion Date
December 1, 2024
Anticoagulation dosing
Patients are dialyzed with only one quarter of their regular anticoagulation dose during the sessions on Tuesday and Thursday
Blood sampling
Blood is sampled at start and at 10, 30, 60, 180, and 240 min after dialysis start for the 4 hours dialysis session, and at start and 10 and 180 min after dialysis start for the 3 hours dialysis session.
Duration of the dialysis session
Patients have a washout with their regular dialysis duration on Saturday, a study session of 4 hours dialysis on Tuesday, and a study session of 3 hours dialysis on Thursday
Choice of the hemodialyzer
Patients are dialyzed with one of the four dialyzers during the entire week, starting at Saturday (i.a. Saturday, Tuesday and Thursday). Block randomization is performed per two weeks. In week 1 and 2, patients are dialyzed with the FX CorAL 800 and the FX 800 Cordiax. In week 3 and 4 of the study, patients are dialyzed with the Solacea 19H and the Xevonta Hi20.
Ghent University Hospital, Ghent
University Hospital, Ghent
OTHER